[Role of CTL in liver injury of patients with HCV infection].
Hiroishi
Kazumasa
K
Second Department of Internal Medicine, Showa University School of Medicine.
Matsumura
Takuya
T
Imawari
Michio
M
D016207:Cytokines / Q000502:physiology; D003713:Dendritic Cells / Q000276:immunology; D053222:Fas Ligand Protein; D006526:Hepatitis C / Q000276:immunology*; D018936:Hepatitis C Antigens / Q000276:immunology; D015395:Histocompatibility Antigens Class I / Q000276:immunology; D007111:Immunity, Cellular; D007157:Immunologic Surveillance; D008562:Membrane Glycoproteins / Q000378:metabolism; D054353:Perforin; D052899:Pore Forming Cytotoxic Proteins; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology* / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D016207:Cytokines; D053222:Fas Ligand Protein; D018936:Hepatitis C Antigens; D015395:Histocompatibility Antigens Class I; D008562:Membrane Glycoproteins; D052899:Pore Forming Cytotoxic Proteins; D011948:Receptors, Antigen, T-Cell; D014409:Tumor Necrosis Factor-alpha; D054353:Perforin